SCI Pharmtech, Inc.

SCI Pharmtech, Inc. Share · TW0004119003 (XTAI) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SCI Pharmtech, Inc.
No Price
Closing Price XTAI 30.04.2026: 47,80 TWD
30.04.2026 05:30
Current Prices from SCI Pharmtech, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTAI: TWSE
TWSE
4119.TW
TWD
30.04.2026 05:30
47,80 TWD
-
Share Float & Liquidity
Free Float 60,34 %
Shares Float 72,12 M
Shares Outstanding 119,51 M
Company Profile for SCI Pharmtech, Inc. Share
SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and specialty chemicals. Its active pharmaceutical ingredients include Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Divalproex Sodium, Duloxetine HCl, Hydroxychloroquine sulfate, Loxoprofen Sodium, Methylphenidate HCl, Pentobarbital Sodium, Probucol, Propafenone HCl, Sodium Valproate, Thiopental, Valproic Acid, Adenine, Cannabidiol, and Dexmethylphenidate HCl. The company's intermediate products comprise Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Diethyl dipropylmalonate, Diethyl ethyl(1-methylbutyl)malonate, Pyrogallolaldehyde, Benzhydrylamine, 1-Benzhydrylazetidin-3-ol, 1-(2-Hydroxyphenyl)-3-phenylpropan-1-one, N-Methyl-4-piperidinol, Ritalinic acid, d-Ritalinic acid HCl, (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol HCl, and (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol. Its intermediate products also consists of (S)-3-(methylmino)-1-(2-thi-enyl)propan-1-ol, (R)-3-(Methylamino)-1-phenylpropanol, (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol, Menthadienol, 5-pentylbenzene-1,3-diol Olivetol, Methyl 2,4-dihydroxy-6-pentylbenzoate, and Ethyl 2,4-dihydroxy-6-pentylbenzoate Ethyl Olivetolate. The company also provides custom manufacturing services. It sells its products in Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, Netherlands, and internationally. The company was incorporated in 1987 and is based in Taoyuan City, Taiwan.

Company Data

Name SCI Pharmtech, Inc.
Company SCI Pharmtech, Inc.
Website https://www.sci-pharmtech.com.tw
Primary Exchange XTAI TWSE
ISIN TW0004119003
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Wen-Chih Chou
Market Capitalization 6 Mrd.
Country Taiwan
Currency TWD
Employees 0,2 T
Address No. 61, Haihu North Road, 33856 Taoyuan City
IPO Date 2004-01-07
Dividends from 'SCI Pharmtech, Inc.'
Ex-Date Dividend per Share
01.07.2025 1,50 TWD
01.07.2024 1,25 TWD
27.07.2023 0,28 TWD
23.08.2021 0,50 TWD
13.07.2020 4,83 TWD
23.07.2019 3,50 TWD
31.07.2018 1,79 TWD
31.07.2017 3,50 TWD
29.07.2016 3,20 TWD
28.07.2015 2,59 TWD

Stock Splits

Date Split
13.10.2023 203:200
27.07.2023 9:8
23.08.2021 6:5
05.08.2014 21:20
15.08.2013 129:125
05.08.2013 26997:25000
04.08.2011 21519:20000
05.08.2010 1099:1000
06.08.2009 5497:5000
23.07.2008 11:10
03.08.2004 43:40

Ticker Symbols

Name Symbol
TWSE 4119.TW
More Shares
Investors who hold SCI Pharmtech, Inc. also have the following shares in their portfolio:
ROGUE RES INC
ROGUE RES INC Share
URBANA CORP.
URBANA CORP. Share